Natural history of spinal and bulbar muscular atrophy (SBMA): a study of 223 Japanese patients - PubMed (original) (raw)
. 2006 Jun;129(Pt 6):1446-55.
doi: 10.1093/brain/awl096. Epub 2006 Apr 18.
Affiliations
- PMID: 16621916
- DOI: 10.1093/brain/awl096
Natural history of spinal and bulbar muscular atrophy (SBMA): a study of 223 Japanese patients
Naoki Atsuta et al. Brain. 2006 Jun.
Abstract
Spinal and bulbar muscular atrophy (SBMA) is an adult-onset motoneuron disease caused by a CAG-repeat expansion in the androgen receptor (AR) gene and for which no curative therapy exists. However, since recent research may provide opportunities for medical treatment, information concerning the natural history of SBMA would be beneficial in planning future clinical trials. We investigated the natural course of SBMA as assessed by nine activities of daily living (ADL) milestones in 223 Japanese SBMA patients (mean age at data collection = 55.2 years; range = 30-87 years) followed from 1 to 20 years. All the patients were diagnosed by genetic analysis. Hand tremor was an early event that was noticed at a median age of 33 years. Muscular weakness occurred predominantly in the lower limbs, and was noticed at a median age of 44 years, followed by the requirement of a handrail to ascend stairs at 49, dysarthria at 50, dysphagia at 54, use of a cane at 59 and a wheelchair at 61 years. Twenty-one of the patients developed pneumonia at a median age of 62 and 15 of them died at a median age of 65 years. The most common cause of death in these cases was pneumonia and respiratory failure. The ages at onset of each ADL milestone were strongly correlated with the length of CAG repeats in the AR gene. However CAG-repeat length did not correlate with the time intervals between each ADL milestone, suggesting that although the onset age of each ADL milestone depends on the CAG-repeat length in the AR gene, the rate of disease progression does not. The levels of serum testosterone, an important triggering factor for polyglutamine-mediated motoneuron degeneration, were maintained at relatively high levels even at advanced ages. These results provide beneficial information for future clinical therapeutic trials, although further detailed prospective studies are also needed.
Similar articles
- CAG repeat size correlates to electrophysiological motor and sensory phenotypes in SBMA.
Suzuki K, Katsuno M, Banno H, Takeuchi Y, Atsuta N, Ito M, Watanabe H, Yamashita F, Hori N, Nakamura T, Hirayama M, Tanaka F, Sobue G. Suzuki K, et al. Brain. 2008 Jan;131(Pt 1):229-39. doi: 10.1093/brain/awm289. Epub 2007 Dec 4. Brain. 2008. PMID: 18056738 - [Clinical manifestations and molecular genetics of spinal bulbar muscular atrophy: report of 5 cases].
Li XH, Zhuang JJ, Xie QY, Li AP, Liang XL, Feng YQ, Fang YY, Li JR, Liang YX. Li XH, et al. Zhonghua Yi Xue Za Zhi. 2007 Jun 19;87(23):1611-5. Zhonghua Yi Xue Za Zhi. 2007. PMID: 17803850 Chinese. - Longitudinal changes of outcome measures in spinal and bulbar muscular atrophy.
Hashizume A, Katsuno M, Banno H, Suzuki K, Suga N, Mano T, Atsuta N, Oe H, Watanabe H, Tanaka F, Sobue G. Hashizume A, et al. Brain. 2012 Sep;135(Pt 9):2838-48. doi: 10.1093/brain/aws170. Epub 2012 Jul 6. Brain. 2012. PMID: 22773541 - Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy.
Adachi H, Waza M, Katsuno M, Tanaka F, Doyu M, Sobue G. Adachi H, et al. Neuropathol Appl Neurobiol. 2007 Apr;33(2):135-51. doi: 10.1111/j.1365-2990.2007.00830.x. Neuropathol Appl Neurobiol. 2007. PMID: 17359355 Review. - [Somatic mosaicism of expanded CAG trinucleotide repeat in spinal and bulbar muscular atrophy (SBMA)].
Tanaka F, Ito Y, Sobue G. Tanaka F, et al. Nihon Rinsho. 1999 Apr;57(4):862-8. Nihon Rinsho. 1999. PMID: 10222780 Review. Japanese.
Cited by
- A phenotypically robust model of spinal and bulbar muscular atrophy in Drosophila.
Richardson K, Sengupta M, Sujkowski A, Libohova K, Harris AC, Wessells R, Merry DE, Todi SV. Richardson K, et al. J Neurosci Res. 2024 Jan;102(1):e25278. doi: 10.1002/jnr.25278. J Neurosci Res. 2024. PMID: 38284836 Free PMC article. - Autophagic and Proteasomal Mediated Removal of Mutant Androgen Receptor in Muscle Models of Spinal and Bulbar Muscular Atrophy.
Cicardi ME, Cristofani R, Crippa V, Ferrari V, Tedesco B, Casarotto E, Chierichetti M, Galbiati M, Piccolella M, Messi E, Carra S, Pennuto M, Rusmini P, Poletti A. Cicardi ME, et al. Front Endocrinol (Lausanne). 2019 Aug 20;10:569. doi: 10.3389/fendo.2019.00569. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31481932 Free PMC article. - Ligand-free mitochondria-localized mutant AR-induced cytotoxicity in spinal bulbar muscular atrophy.
Feng X, Cheng XT, Zheng P, Li Y, Hakim J, Zhang SQ, Anderson SM, Linask K, Prestil R, Zou J, Sheng ZH, Blackstone C. Feng X, et al. Brain. 2023 Jan 5;146(1):278-294. doi: 10.1093/brain/awac269. Brain. 2023. PMID: 35867854 Free PMC article. - Genetic approaches to the treatment of inherited neuromuscular diseases.
Ravi B, Antonellis A, Sumner CJ, Lieberman AP. Ravi B, et al. Hum Mol Genet. 2019 Oct 1;28(R1):R55-R64. doi: 10.1093/hmg/ddz131. Hum Mol Genet. 2019. PMID: 31227836 Free PMC article. Review. - Sexual dysfunction and male infertility.
Lotti F, Maggi M. Lotti F, et al. Nat Rev Urol. 2018 May;15(5):287-307. doi: 10.1038/nrurol.2018.20. Epub 2018 Mar 13. Nat Rev Urol. 2018. PMID: 29532805 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials